{"id":90779,"date":"2023-04-24T16:09:00","date_gmt":"2023-04-24T14:09:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=90779"},"modified":"2023-04-24T15:34:29","modified_gmt":"2023-04-24T13:34:29","slug":"tubules-bristol-myers-squibb","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/90779\/tubules-bristol-myers-squibb\/","title":{"rendered":"Tubulis collaborates with Bristol Myers Squibb and receives up to $1 billion"},"content":{"rendered":"
\n

The goal of the collaboration between Tubulis and Bristol Myers Squibb is to develop differentiated antibody-drug conjugates, so-called ADCs, for use in the treatment of cancer. Munich startup<\/a> Under the agreement, BioNTech will receive an upfront payment of $22.75 million, plus potential milestone payments of over $1 billion for development, regulatory approval and commercialization, as well as royalties on the resulting marketed products. <\/p>\n\n\n\n

Bristol Myers Squibb: \u201cPromising role in cancer therapy\u201d<\/h2>\n\n\n\n

\u201cThis strategic agreement with Bristol Myers Squibb is an important validation of the potential of our approach to developing next-generation ADC-based therapeutics, as well as our cutting-edge ADC conjugation technologies that enable advanced ADC design to treat tumors with high unmet medical need,\u201d <\/p><\/blockquote>\n\n\n\n

says Dominik Schumacher<\/strong>, CEO and co-founder of Tubulis. <\/p>\n\n\n\n

"We are committed to changing treatment paradigms in oncology and delivering better outcomes for cancer patients. Joining forces with BMS, a global leader in oncology, is a significant step toward achieving this goal."<\/p><\/blockquote>\n\n\n\n

Emma Lees<\/strong>, head of cancer research at Bristol Myers Squibb, says:<\/p>\n\n\n\n

\u201cADCs play a promising role in cancer therapy, and Tubulis\u2019 differentiated technologies offer the opportunity to overcome current challenges in developing safe and effective ADC therapeutics.\u201d<\/p><\/blockquote>\n\n\n\n

Tubule has the Munich Startup Insights<\/a> According to the company, 72 million euros in investments had already been raised before the deal, most recently in May last year 60 million euros as part of its Series B round<\/a>.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Tubulis has entered into a strategic partnership with the American pharmaceutical company Bristol Myers Squibb. The startup, based at the IZB in Martinsried, will receive $22.75 million as an upfront payment and up to $1 billion in total funding.<\/p>","protected":false},"author":26,"featured_media":90782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1,5635],"tags":[52,1499,4001],"acf":[],"yoast_head":"\nTubulis arbeitet mit Bristol Myers Squibb zusammen - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das IZB-Startup Tubulis hat eine strategische Partnerschaft mit dem amerikanischen Pharma-Konzern Bristol Myers Squibb geschlossen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/90779\/tubules-bristol-myers-squibb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tubulis arbeitet mit Bristol Myers Squibb zusammen - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das IZB-Startup Tubulis hat eine strategische Partnerschaft mit dem amerikanischen Pharma-Konzern Bristol Myers Squibb geschlossen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/90779\/tubules-bristol-myers-squibb\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T14:09:00+00:00\" \/>\n<meta name=\"author\" content=\"Simon Tischer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simon Tischer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/\",\"url\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/\",\"name\":\"Tubulis arbeitet mit Bristol Myers Squibb zusammen - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\",\"datePublished\":\"2023-04-24T14:09:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\"},\"description\":\"Das IZB-Startup Tubulis hat eine strategische Partnerschaft mit dem amerikanischen Pharma-Konzern Bristol Myers Squibb geschlossen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\",\"width\":2400,\"height\":1600,\"caption\":\"Tubulis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tubulis arbeitet mit Bristol Myers Squibb zusammen und erh\u00e4lt bis zu 1 Milliarde Dollar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d\",\"name\":\"Simon Tischer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g\",\"caption\":\"Simon Tischer\"},\"description\":\"Von Dezember 2015 bis Juni 2023 war Simon Tischer als Redakteur f\u00fcr Munich Startup t\u00e4tig.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tubulis collaborates with Bristol Myers Squibb - Munich Startup","description":"The IZB startup Tubulis has entered into a strategic partnership with the American pharmaceutical company Bristol Myers Squibb.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/90779\/tubules-bristol-myers-squibb\/","og_locale":"en_US","og_type":"article","og_title":"Tubulis arbeitet mit Bristol Myers Squibb zusammen - Munich Startup","og_description":"Das IZB-Startup Tubulis hat eine strategische Partnerschaft mit dem amerikanischen Pharma-Konzern Bristol Myers Squibb geschlossen.","og_url":"https:\/\/cms.munich-startup.net\/en\/90779\/tubules-bristol-myers-squibb\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2023-04-24T14:09:00+00:00","author":"Simon Tischer","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Simon Tischer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/","url":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/","name":"Tubulis collaborates with Bristol Myers Squibb - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","datePublished":"2023-04-24T14:09:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d"},"description":"The IZB startup Tubulis has entered into a strategic partnership with the American pharmaceutical company Bristol Myers Squibb.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","width":2400,"height":1600,"caption":"Tubulis"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/90779\/tubulis-bristol-myers-squibb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Tubulis arbeitet mit Bristol Myers Squibb zusammen und erh\u00e4lt bis zu 1 Milliarde Dollar"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/cab6cd082a88a9e4b2d6ca61a9031a4d","name":"Simon Tischer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0768e5403c34aa0074a7e723cd3a2795?s=96&d=blank&r=g","caption":"Simon Tischer"},"description":"From December 2015 to June 2023, Simon Tischer worked as an editor for Munich Startup.","url":"https:\/\/cms.munich-startup.net\/en\/author\/tischer\/"}]},"og_image":[{"width":2400,"height":1600,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1682343270:24","_edit_last":"24","_yoast_wpseo_focuskw":"Bristol","_yoast_wpseo_metadesc":"Das IZB-Startup Tubulis hat eine strategische Partnerschaft mit dem amerikanischen Pharma-Konzern Bristol Myers Squibb geschlossen.","_yoast_wpseo_linkdex":"76","_thumbnail_id":"90782","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"1","_wp_old_date":"","_yoast_wpseo_title":"Tubulis arbeitet mit Bristol Myers Squibb zusammen %%sep%% %%sitename%%","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/90779"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=90779"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/90779\/revisions"}],"predecessor-version":[{"id":90801,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/90779\/revisions\/90801"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/90782"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=90779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=90779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=90779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}